First step to artificial life: scientists add two new letters to DNA
02 December 2017
In a major step toward creating artificial life, US researchers have developed a living organism that incorporates both natural and artificial DNA and is capable of creating entirely new, synthetic proteins.
The work, published in the journal Nature, brings scientists closer to the development of designer proteins made to order in a laboratory.
Previous work by Floyd Romesberg, a chemical biologist at the Scripps Research Institute in La Jolla, California, showed that it was possible to expand the genetic alphabet of natural DNA beyond its current four letters: adenine (A), cytosine (C), guanine (G) and thymine (T).
As students of science would be aware, DNA is the body's instruction manual. But its language is only written in four letters: A, T, C, and G. RNA, the photocopy of the instructions that the cell actually uses, replaces the Ts with the letter U.
Back in 2014, scientists at the Scripps Research Institute in California, including Romesberg and colleagues, reported that they'd engineered a strain of E coli bacteria whose DNA used a whole new pair of letters, nicknamed X and Y. That same team now reports that they've gotten the bacteria to actually use these new letters. The resulting biological possibilities seem endless.
In the latest work, Romesberg's team has shown that this partially synthetic form of E coli can take instructions from this hybrid genetic alphabet to make new proteins.
''This is the first time ever a cell has translated a protein using something other than G, C, A or T,'' Romesberg said.
Although the actual changes to the organism were small, the feat is significant, he told Reuters in a telephone interview. ''It's the first change to life ever made.''
It's a goal Romesberg has been working toward for the past 20 years. Creating new forms of life, however, is not the main point. Romesberg is interested in using this expanded genetic alphabet to create new types of proteins that can be used to treat disease.
In 2014, he formed a company called Synthorx Inc., which is working on developing new protein-based treatments.
''A lot of proteins that you want to use as drugs get cleared in the kidney very quickly,'' Romesberg said. The new system would allow scientists to attach fat molecules to drugs to keep them in the body longer.
Romesberg is aware that the creation of semi-synthetic organisms might raise concerns of hybrid life forms spreading beyond the lab, but the system they used makes such an escape unlikely.
For example, in natural DNA, base pairs are attracted to each other through the bonding of hydrogen atoms. Romesberg's X and Y bases are attracted through an entirely different process, which prevents them from accidentally bonding with natural bases.
And because cells cannot make their own X and Y without the addition of certain chemicals, the semi-synthetic organisms cannot live outside of a laboratory.
''They can't escape,'' Romesberg said. ''There's no 'Jurassic Park' scenario.''
Still, as Nature puts it, the sky is the limit if the paper is to be taken at its word. ''Thus, the reported semi-synthetic organism is likely to be just the first of a new form of semi-synthetic life that is able to access a broad range of forms and functions not available to natural organisms,'' the paper said.